This Warner Bros Discovery Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Monday
Avi Kapoor 3 months ago
Trading IdeasNewsAnalyst RatingsDowngrades
Top Wall Street analysts changed outlook on several top stocks. See all changes on analyst ratings page.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Seaport Global analyst David Joyce downgraded Warner Bros Discovery Inc (NASDAQ:WBD) from Buy to Neutral. Warner Bros. Discovery shares closed at $25.77 on Friday. See how other analysts view this stock.
- B of A Securities analyst Ebrahim Poonawala downgraded Huntington Bancshares Inc (NASDAQ:HBAN) from Buy to Neutral and cut the price target from $20 to $18.5. Huntington Bancshares closed at $17.36 on Friday. See how other analysts view this stock.
- Barclays analyst Laurence Whyatt downgraded Anheuser-Busch Inbev SA (NYSE:BUD) from Overweight to Equal-Weight. Anheuser-Busch shares closed at $81.66 on Friday. See how other analysts view this stock.
- Wolfe Research analyst Kalpit Patel downgraded Corcept Therapeutics Inc (NASDAQ:CORT) from Peer Perform to Underperform and announces $50 price target Corcept Therapeutics shares closed at $95.36 on Friday. See how other analysts view this stock.
Considering buying WBD stock? Here’s what analysts think:
Photo via Shutterstock